An apparatus for implanting electrodes in neural tissue to connect a neural modulator to the tissue to send and receive signals from the neural tissue and a method for implanting the electrodes.
|
1. A system for modulating neural tissue in a mammal comprising:
a. an implantable neural modulator;
b. an electrode array of micro-fabricated ultrathin tines;
c. a micro-fabricated communication bus with insulated signal lines connecting said set of tines to said neural modulator;
d. wherein said tines are elongated in shape for insertion into living tissue with an electrically insulated exterior with the exception of at least two electrodes on an exterior of each tine of said tines, said electrodes being individually connected by a separate insulated signal line of said communication bus to said stimulator; and
e. wherein said set of tines are of varying length so said at least one electrode on each of said tines of said set of tines is positioned at varying depths in tissue as said set of tines are implanted in a target tissue.
19. An electrical connection device for connecting a medical device to living neural tissue comprising:
a. a ribbon connector with a first end for connecting to a medical device and a tine assembly at a second end for insertion into a target tissue;
b. said tine assembly has a plurality of tines for insertion into the target tissue and each tine of said plurality of tines has an electrically insulated exterior with the exception of at least two electrodes on it's surface, said electrodes being connected by an individual insulated line through said ribbon connector to said first end of said ribbon connector, wherein said insulated exterior is an insulating sealing thin film moisture barrier layer and ion diffusion barrier layer;
c. said plurality of tines are of different lengths to thereby place said at least one electrode on each of said tine of said plurality of tines at different depths of the target tissue; and
d. wherein each individual electrode with said individual insulated line can transmit a separate signal or receive a separate signal from the target tissue.
16. A method for implanting an electrode array into target brain tissue of a mammal comprising the steps of:
a. encasing an electrode array with an attached ribbon connector in a split sheath inserter, such that the end of the electrode array with tines is retracted slightly from the front tip of the split sheath inserter and does not extend out of the front end, and the ribbon cable extends out of the back end of the split sheath inserter;
b. positioning a first end of an insertion rod at a back end of the electrode array and having a second end extending up and out of the end of the split sheath inserter;
c. Performing a craniotomy in the subject into which the electrode array will be embedded, the hole being cut at a position in the skull to allow insertion of the split sheath inserter to the outside surface of the tissue to be targeted;
d. positioning the split sheath inserter for insertion into the brain of the subject through the hole cut in the skull;
e. inserting the split sheath inserter with electrode array, ribbon connector and insertion rod encased in the split sheath inserter at a preset coarse rate until the leading end of the split sheath inserter contacts the outer surface of the target tissue, with navigation guidance e.g. through the brain provided by existing neurosurgical imaging tools;
f. holding the split sheath inserter still and slowly and precisely inserting the tines at the end of the electrode array into the target tissue by pushing on the back of the electrode array with an insertion rod that is compatible with and connected to existing neurosurgical apparatus (e.g., a hydraulic micro-drive) until the tines are fully embedded in the target tissue, the insertion being informed by recording and monitoring neural activity and/or by stimulating target neural tissue to assess the response, behavior, or perception of the subject;
g. withdrawing the split sheath inserter and insertion rod; and
h. positioning the attached stimulator on the skull at the site of the craniotomy.
2. The system of
3. The system of
4. The system of
5. The system of
6. The system of
7. The system of
9. The system of
10. The system of
11. The system of
12. The system of
13. The system of
14. The system of
15. The system of
18. The method of
20. The electrical connection device of
21. The electrical connection device of
22. The electrical connection device of
23. The electrical connection device of
24. The electrical connection device of
25. The electrical connecting device of
26. The electrical connecting device of
|
This application claims the benefit of priority under applicable US laws of U.S. Provisional Application Ser. No. 62/610,635 filed on Dec. 27, 2017 the content of which is relied upon and incorporated herein by reference in its entirety.
The present invention relates to a system and method for implanting electrodes in living tissue, more specifically to implanting electrodes in brain tissue.
Medical science for some time has been developing various ways to stimulate living tissue for a variety of purposes. Among these are restoring the ability of a paralyzed person to control and move their limbs, as well as for restoration of sight. Deep brain stimulation (DBS), an example of this effort, is a rapidly growing medical field, which is used for a number of movement disorders (such as Parkinson's disease), seizure disorders (e.g. epilepsy), chronic pain, mood disorders, neurological and psychiatric conditions. In DBS, electrodes are placed in the brain, somewhere below the cortex, in either white matter fiber tracts or nuclei in the brain, and are used to stimulate specific regions for the alleviation of symptoms. In addition, the electrodes used for DBS also can be used to stimulate cortical neurons or to record cortical signals, often in conjunction with implanted stimulating systems.
The implantation of electrodes, DBS or otherwise, creates a brain-machine interface (BMI). For example, electrode arrays implanted into the motor regions of the cortex could utilize signals generated by a patient thinking about a physical movement, and convert this to an electrical signal to stimulate the motor cortex and initiate that movement. The potential for such thought-invoked control signals is significant.
One of the main challenges in the field has been the development of electrodes (and stimulation paradigms) that can selectively activate specific neurons or neuronal pathways. For example, a recent study has shown that the DBS electrode location was highly correlated with clinical improvement in Parkinson's patients, with structural connectivity to the supplementary motor cortex linked to a positive outcome, whilst functional connectivity to the primary motor cortex led to worse outcomes. In addition, ≈70% of the cortical neurons lie below the surface, and so surface electrodes are not able to effectively activate the deeper layers. For example, work by the NIH found that surface electrodes placed onto the occipital lobe produced much lower spatial resolution and required 100× greater charge to reach stimulation threshold vs. penetrating microelectrodes placed into the occipital cortex. It is clear that superficial diffuse electrical stimulation does not provide optimal patient benefit, and hence our invention aims to address this issue via smaller electrodes that are microfabricated within novel flexible arrays, which because of their small size and flexible mechanical properties can be passed into neural tissue (e.g., cortical or subcortical structures) with minimal damage. This invention also describes the means to deploy our ultra-thin microfabricated electrode arrays that are connected to local or external neuromodulation circuits; the arrays require special techniques and tools for surgical implantation because of their flexible nature. The small size of our microfabricated electrodes enhances the ability to selectively stimulate target nerve cells or nerve pathways, which should enhance the clinical benefits for patients.
The present inventions to solve the problems discussed provides a system for modulating neural tissue in a mammal having: a) an implantable neural modulator; b) an electrode array of micro-fabricated ultrathin tines; c) a micro-fabricated communication bus with insulated signal lines connecting the set of tines to the neural modulator; d) wherein the tines are elongated in shape for insertion into living tissue with an electrically insulated exterior with the exception of at least one electrode on an exterior of each tine of the tines, the electrodes being individually connected by a separate insulated signal line of the communication bus to the stimulator; and e) wherein the set of tines are of varying length so the at least one electrode on each of the tines of the set of tines is positioned at varying depths in tissue as the set of tines are implanted in a target tissue. In a further aspect of the system the electrode array and ribbon connector can consist of a ribbon connector and electrode array micro-fabricated as two separate devices and then joined, or the ribbon connector and electrode array can be micro-fabricated as one unitary device.
In a further aspect of the system a spatial distribution of the tines in the target tissue is determined by fabrication parameters of the tines, the fabrication parameters being control of a net tensile or compressive stress of the material that the tines are fabricated from during a micro-fabrication process. In yet another aspect of the system there is at least one electrode on a tine is at a plurality of electrodes with each the electrode having its own separate insulated signal line in the communication buss. In yet another aspect of the system a tine of the set of tines can be up to 4 mm long and 2 to 10 microns in diameter. In yet a further aspect the mammal is a human and the target tissue is at least one of the LGN's of the human. In still another aspect the neural modulator is placed at the edge of the human's brain and the ribbon connector runs from the neural modulator to the electrode array to thereby communicatively connect them with a source of stimulating signals and also receive neural signals from the LGN. In yet another aspect the source of stimulating signals is a signal from a camera.
In a further aspect the shape of the elongated shaped tines is selected from a group consisting tines that are cylindrical in shape, spike shaped, and flat shaped. In yet another aspect of the system the electrode is configured in a manner selected from a group consisting of an electrode outer surface coplanar with the surface of the tine, and an electrode outer surface projecting out from the tine surface from 1 to 30 microns. In yet another aspect the system includes a signal processor incorporated into to the electrode array to process received signals generated by the target tissue, amplify them and retransmit them to the neural modulator, or to distribute received stimulus signals on a channel to one of a plurality of nearby electrodes.
In another aspect of the invention, it provides a method for implanting an electrode array into target brain tissue of a mammal having the steps of: a) encasing an electrode array with an attached ribbon connector in a split sheath inserter, such that the end of the electrode array with tines is retracted slightly from the front tip of the split sheath inserter and does not extend out of the front end, and the ribbon cable extends out of the back end of the split sheath inserter; b) positioning a first end of an insertion rod at a back end of the electrode array and having a second end extending up and out of the end of the split sheath inserter; c) Performing a craniotomy in the subject into which the electrode array will be embedded, the hole being cut at a position in the skull to allow insertion of the split sheath inserter to the outside surface of the tissue to be targeted; d) positioning the split sheath inserter for insertion into the brain of the subject through the hole cut in the skull; e) inserting the split sheath inserter with electrode array, ribbon connector and insertion rod encased in the split sheath inserter at a preset coarse rate until the leading end of the split sheath inserter contacts the outer surface of the target tissue, with navigation guidance e.g. through the brain provided by existing neurosurgical imaging tools; f) holding the split sheath inserter still and slowly and precisely inserting the tines at the end of the electrode array into the target tissue by pushing on the back of the electrode array with an insertion rod that is compatible with and connected to existing neurosurgical apparatus (e.g., a hydraulic micro-drive) until the tines are fully embedded in the target tissue, the insertion being informed by recording and monitoring neural activity and/or by stimulating target neural tissue to assess the response, behavior, or perception of the subject; g) withdrawing the split sheath inserter and insertion rod; and h) positioning the attached stimulator on the skull at the site of the craniotomy.
In a further aspect of the method the mammal is a human and the target tissue is the LGN. In yet another aspect of the method it includes an initial step of a scanning or imaging the target tissue prior to the step of inserting the split sheath inserter with electrode array and ribbon connector to thereby precisely locate the position of the target tissue to insert the tines into; alternatively, such mapping of the target tissue may be accomplished by probing and stimulating with microprobes at varied positions and depths.
In another variation of the invention it provides an electrical connection device for connecting a medical device to living neural tissue having: a) a ribbon connector with a first end for connecting to a medical device and a tine assembly at a second end for insertion into a target tissue; b) the tine assembly has a plurality of tines for insertion into the target tissue and each tine of the plurality of tines has an electrically insulated exterior with the exception of at least one electrode on it's surface the electrode being connected by an individual insulated line through the ribbon connector to the first end of the ribbon connector; c) the plurality of tines are of different lengths to thereby place the at least one electrode on each of the tine of the plurality of tines at different depths of the target tissue; and d) wherein each individual electrode with the individual insulated line can transmit a separate signal or receive a separate signal from the target tissue.
In another aspect of this variation of the invention the neural modulator can be connected to the first end of the electrical connection device and thereby transmit or receive signals on each of the individually insulated lines to each of the electrodes in the target tissue. In yet another aspect of the invention, the electrical connection device leads to a plurality of electrodes on a tine, each with a separate insulated line to the connector at the first end. In yet another aspect, the at least one electrode on a tine is a plurality of electrodes on the tine, and wherein at least two electrodes of the plurality of electrodes share an insulated line to the first end of the ribbon connector. In yet another aspect of the tine, the assembly includes signal processing circuits to process signals received by the electrode from the target tissue for transmission to the first end of the ribbon connector for reception by a medical device attached to the first end. In yet another aspect of the invention the neural modulator processes signals received from the target tissue to adjust the signals it then transmits to the target tissue over the connected insulated lines to the tines and thence to the electrodes thereon.
Additional features and advantages will be set forth in the detailed description which follows, and in part will be readily apparent to those skilled in the art from the description or recognized by practicing the embodiments as described in the written description and claims hereof, as well as the appended drawings.
It is to be understood that both the foregoing general description and the following detailed description are merely exemplary, and are intended to provide an overview or framework to understand the nature and character of the claims.
The accompanying drawings are included to provide a further understanding, and are incorporated in and constitute a part of this specification. The drawings illustrate one or more embodiment(s), and together with the description serve to explain principles and operation of the various embodiments.
I. Overview
U.S. Pat. No. 8,396,561 titled “A Visual Prosthesis and Method of Creating Visual Perception” of Pezaris et al., which is incorporated herein by reference, discloses a method for providing a mammal with visual information from an artificial source. This approach implants electrodes into the lateral geniculate nucleus (LGN), which is a structure along the visual pathway from the eye to the brain.
As noted, the present invention relates to electrodes implantable in living tissue and methods for implanting them in living tissue. Although the embodiment described in detail herein provides an example of an electrode array for implanting in brain tissue, specifically, laminar lateral geniculate nucleus (LGN) neural tissue, once those skilled understand all of the particulars of the invention or inventions described herein they will understand the applicability of the invention to other situations where tissue or nerve cells can be stimulated to rehabilitate, activate or restore the functioning of an organ, appendage, or part of a living human animal, etc. Such situations may for example use of the arrays to modulate the activity of other laminar neural tissue structures.
II. Electrode Array and Connector Structure
The three components of electrode assembly 41 can be wholly passive or alternatively they can contain active electronic devices for various purposes.
Each tine 51 from the point where it connects 55 can be up to 4 mm in length. In the embodiment depicted, each tine is also about five to six microns in diameter or width.
Thus referring to
III. Fabrication
As noted above and discussed below the tines, electrode array and ribbon connector are semiconductor structures and fabricated by such fabrication techniques whether they are fabricated as one unit or as a separate ribbon connector and electrode array and them connected. One of the important considerations in fabricating the electrode array and the ribbon connector either as two separate structures that are later joined or as a unitary structure is to minimize stress during the fabrication process. As is well known in the technology of semiconductor fabrication control of stress in laying down the films is achieved by precise control of temperature and pressure, among other parameters. Fabricated parts with too much stress tend to curl or become deformed in other ways, creating issues with the ribbon connector and tines on the electrode array by not having sufficient straightness, etc. Thus, during the micro-fabrication process there is a need to control the net tensile or compressive stress of the material to assure the straightness and proper formation of the tines.
The structures depicted in
IV. Implant Apparatus
The ribbon connector and electrode array, as noted above are very flexible and resilient given the materials they are made from. Also, as noted above when originally fabricated both are flat. In order to prepare the combined ribbon connector and electrode array for deployment during a surgical procedure they need to be rolled into a cylindrical shape for positioning in the split sheath inserter.
Precision positioning instrument 161 has base 162 attached to operating table 158. Support strut 163 attaches to base 162. Support arm 164 attaches to strut 163 and holds precision positioning mechanism 165.
Referring to
As depicted in
Typically, the physician or physicians performing the procedure will be using a system similar to that depicted in
V. Method of Implanting
As depicted in
Perform a craniotomy in the skull of the subject at a point above the target tissue (e.g., LGN as an example of a deep brain structure, or e.g. a cortical location) into which the electrode array will be inserted 204. Insert the loaded split sheath inserter into the brain coarsely towards the target tissue to the predetermined position on the target organ the LGN 205 using the gross positioning instrument. When the tip of the loaded split sheath inserter reaches the outer edge of the target tissue, stop coarse insertion of the split sheath inserter 206.
Using a hydraulic micro-drive attached to the insertion rod, push the tines of the array slowly out of the split sheath inserter so that it penetrates the target tissue to the desired depth 207. Remove the split sheath inserter in the standard manner by parting the opposing handles of the split sheath inserter 208. Affix the previously-connected packaged stimulator the end of the ribbon cable in the opening previously made in the skull of the patient 209.
It will be apparent to those skilled in the art that various modifications and variations can be made without departing from the spirit or scope of the invention. Since modifications combinations, sub-combinations and variations of the disclosed embodiments incorporating the spirit and substance of the invention may occur to persons skilled in the art, the invention should be construed to include everything within the scope of the appended claims and their equivalents.
Shire, Douglas B, Ayton, Lauren N, Wong, Patricia I, Gingerich, Marcus D
Patent | Priority | Assignee | Title |
Patent | Priority | Assignee | Title |
5823941, | Oct 23 1995 | JEROME SHAUNNESSEY | Apparatus for directing the movement of an endoscopic surgical laser especially for use in vaporizing brain tumors |
6011996, | Jan 20 1998 | Medtronic, Inc | Dual electrode lead and method for brain target localization in functional stereotactic brain surgery |
8396561, | Dec 22 2006 | General Hospital Corporation | Visual prosthesis and methods of creating visual perceptions |
9107515, | Sep 12 2005 | RTC Industries, Inc. | Product management display system with trackless pusher mechanism |
9216015, | Oct 28 2004 | VYCOR MEDICAL, INC | Apparatus and methods for performing brain surgery |
9247895, | Mar 21 2014 | Pacesetter, Inc. | Systems and methods for performing deep brain stimulation |
9386974, | Oct 28 2004 | VYCOR MEDICAL, INC | Apparatus and methods for performing brain surgery |
9604060, | Mar 11 2014 | Oregon Health & Science University | Deep brain electrode placement and stimulation based on brown adipose tissue temperature |
20040002635, | |||
20070106143, | |||
20090124965, | |||
20100198297, | |||
20140148729, | |||
20150045642, | |||
20170113048, | |||
20180093099, | |||
, |
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
Dec 27 2018 | Bionic Eye Technologies, Inc. | (assignment on the face of the patent) | / | |||
Jan 23 2019 | SHIRE, DOUGLAS B | BIONIC EYE TECHNOLOGIES, INC | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 049766 | /0300 | |
Jan 23 2019 | AYTON, LAUREN N | BIONIC EYE TECHNOLOGIES, INC | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 049766 | /0300 | |
Jan 23 2019 | WONG, PATRICIA I | BIONIC EYE TECHNOLOGIES, INC | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 049766 | /0300 | |
Jan 23 2019 | GINGERICH, MARCUS D | BIONIC EYE TECHNOLOGIES, INC | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 049766 | /0300 | |
Mar 19 2021 | Massachusetts Eye and Ear Infirmary | NATIONAL INSTITUTES OF HEALTH NIH , U S DEPT OF HEALTH AND HUMAN SERVICES DHHS , U S GOVERNMENT | CONFIRMATORY LICENSE SEE DOCUMENT FOR DETAILS | 062613 | /0423 |
Date | Maintenance Fee Events |
Dec 27 2018 | BIG: Entity status set to Undiscounted (note the period is included in the code). |
Jan 23 2019 | SMAL: Entity status set to Small. |
Date | Maintenance Schedule |
Apr 06 2024 | 4 years fee payment window open |
Oct 06 2024 | 6 months grace period start (w surcharge) |
Apr 06 2025 | patent expiry (for year 4) |
Apr 06 2027 | 2 years to revive unintentionally abandoned end. (for year 4) |
Apr 06 2028 | 8 years fee payment window open |
Oct 06 2028 | 6 months grace period start (w surcharge) |
Apr 06 2029 | patent expiry (for year 8) |
Apr 06 2031 | 2 years to revive unintentionally abandoned end. (for year 8) |
Apr 06 2032 | 12 years fee payment window open |
Oct 06 2032 | 6 months grace period start (w surcharge) |
Apr 06 2033 | patent expiry (for year 12) |
Apr 06 2035 | 2 years to revive unintentionally abandoned end. (for year 12) |